CANADA LIFE ASSURANCE Co - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 143 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2016. The put-call ratio across all filers is 0.84 and the average weighting 0.0%.

Quarter-by-quarter ownership
CANADA LIFE ASSURANCE Co ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2018$24,000
-17.2%
10,2750.0%0.00%
Q4 2017$29,0000.0%10,2750.0%0.00%
Q3 2017$29,000
+16.0%
10,2750.0%0.00%
Q2 2017$25,000
-32.4%
10,2750.0%0.00%
Q1 2017$37,0000.0%10,2750.0%0.00%
Q4 2016$37,000
-54.9%
10,275
-50.0%
0.00%
Q3 2016$82,000
+82.2%
20,550
+100.0%
0.00%
Q2 2016$45,000
+15.4%
10,2750.0%0.00%
Q1 2016$39,000
-75.8%
10,2750.0%0.00%
-100.0%
Q4 2015$161,000
+47.7%
10,2750.0%0.00%
Q3 2015$109,000
-57.9%
10,2750.0%0.00%
-100.0%
Q2 2015$259,000
-9.4%
10,2750.0%0.00%0.0%
Q1 2015$286,000
+52.9%
10,2750.0%0.00%0.0%
Q4 2014$187,000
+39.6%
10,2750.0%0.00%
Q3 2014$134,000
+91.4%
10,275
+139.0%
0.00%
Q2 2014$70,000
-6.7%
4,3000.0%0.00%
Q1 2014$75,000
-28.6%
4,3000.0%0.00%
Q4 2013$105,0004,3000.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2016
NameSharesValueWeighting ↓
KLP Enterprises, LLC 6,865,000$3,096,000100.00%
TSP Capital Management Group, LLC 698,674$1,549,0000.79%
Meditor Group Ltd 6,312,700$2,847,0000.61%
Telemetry Investments, L.L.C. 186,200$84,0000.04%
GSA CAPITAL PARTNERS LLP 1,270,500$573,0000.03%
Benchmark Capital Advisors 53,400$24,0000.02%
BOENNING & SCATTERGOOD, INC. 80,150$36,0000.01%
NJ State Employees Deferred Compensation Plan 80,000$36,0000.01%
Centiva Capital, LP 121,720$55,0000.01%
Overbrook Management Corp 48,611$22,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders